MedPath

武汉人福药业有限责任公司

Ownership
-
Established
1997-06-02
Employees
-
Market Cap
-
Website
www.rfyy.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

69

NMPA:69

Drug Approvals

Levodopa and Benserazide Hydrochloride Tablets

Product Name
多巴丝肼片
Approval Number
国药准字H20254379
Approval Date
May 27, 2025
NMPA

Levodopa and Benserazide Hydrochloride Tablets

Product Name
多巴丝肼片
Approval Number
国药准字H20253650
Approval Date
Mar 18, 2025
NMPA

Oxcarbazepine Oral Suspension

Product Name
奥卡西平口服混悬液
Approval Number
国药准字H20253025
Approval Date
Jan 2, 2025
NMPA

Finasteride Capsules

Product Name
意安林
Approval Number
国药准字H20041189
Approval Date
Oct 17, 2024
NMPA

Calcium Folinate for Injection

Product Name
注射用亚叶酸钙
Approval Number
国药准字H20058263
Approval Date
Sep 18, 2024
NMPA

Aciclovir for Injection

Product Name
注射用阿昔洛韦
Approval Number
国药准字H20013057
Approval Date
Sep 18, 2024
NMPA

Methionine and Vitamin B1 Injection

Product Name
甲硫氨酸维B1注射液
Approval Number
国药准字H20056537
Approval Date
Sep 18, 2024
NMPA

Aciclovir for Injection

Product Name
注射用阿昔洛韦
Approval Number
国药准字H20045136
Approval Date
Sep 18, 2024
NMPA

Methionine and Vitamin B1 for Injection

Product Name
保甲维
Approval Number
国药准字H20051961
Approval Date
Sep 18, 2024
NMPA

Deproteinized Calf Blood Extractives Injection

Product Name
小牛血去蛋白提取物注射液
Approval Number
国药准字H20046413
Approval Date
Sep 18, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.